Level Four Advisory Services’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,327
| Closed | -$201K | – | 816 |
|
|
2025
Q1 | $201K | Buy |
8,327
+925
| +12% | +$22.3K | 0.01% | 719 |
|
|
2024
Q4 | $298K | Buy |
7,402
+174
| +2% | +$7K | 0.01% | 628 |
|
|
2024
Q3 | $524K | Sell |
7,228
-5,206
| -42% | -$378K | 0.02% | 497 |
|
|
2024
Q2 | $659K | Sell |
12,434
-19,762
| -61% | -$1.05M | 0.03% | 422 |
|
|
2024
Q1 | $599K | Buy |
32,196
+822
| +3% | +$15.3K | 0.03% | 420 |
|
|
2023
Q4 | $584K | Buy |
31,374
+14,638
| +87% | +$272K | 0.03% | 424 |
|
|
2023
Q3 | $185K | Sell |
16,736
-34,206
| -67% | -$379K | 0.01% | 691 |
|
|
2023
Q2 | $826K | Buy |
50,942
+39,342
| +339% | +$638K | 0.05% | 333 |
|
|
2023
Q1 | $193K | Buy |
+11,600
| New | +$193K | 0.01% | 702 |
|